The Role of Early Nursing Intervention in the High-risk Population of Gestational Diabetes
NCT ID: NCT06997835
Last Updated: 2025-05-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
200 participants
INTERVENTIONAL
2025-01-01
2025-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Early Nutrition Intervention on the Incidence of High-risk Patients With Gestational Diabetes
NCT03550976
Effect of Early Lifestyle Intervention on Perinatal Outcomes in High-risk Women for Gestational Hyperglycemia
NCT07141173
Gestational Diabetes Mother-infant Cohort
NCT06021691
The Early Diagnosis of Gestational Diabetes Mellitus Study
NCT02740283
The Project for Managing Cardiometabolic Risk in Women Diagnosed With Gestational Diabetes Mellitus
NCT06648174
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group
Control group:The interactive management nursing model on the wechat platform
The intervention subjects of the control group: targeted at the pregnant and postpartum women themselves. Specifically, conduct routine outpatient prenatal examinations and health education for pregnant women. Regularly receive health education and pregnancy guidance intervention provided by the wechat platform. It includes: ① Setting specific wechat ringtones, 60-second voice messages and picture reminders every day; ② Basic knowledge education every Monday ③ Dietary guidance is provided every Tuesday. ④ Exercise guidance every Wednesday ⑤ Guidance on blood glucose monitoring every Thursday; Weight guidance is provided every Friday.
Intervention group
Intervention group:Family-centered early care intervention
The intervention subjects of the intervention group were parturients and their primary caregivers (spouses and parents).
The specific measures are as follows:
1. Establish a family-centered healthcare team (FCC) It includes one chief physician, two attending physicians, one diabetes specialist nurse, two responsible nurses, one psychotherapist, and one nutritionist. The organization members will conduct FCC concept learning and knowledge training.
2. Interactive management nursing model on the wechat platform
* Set specific wechat ringtones, 60-second voice messages and picture reminders every day;
* Basic knowledge education every Monday; ③. Dietary guidance every Tuesday;
④. Exercise guidance every Wednesday;
⑤ Guidance on blood glucose monitoring every Thursday;
⑥. Weight guidance every Friday;
⑦. Strengthen home care guidance every Saturday and Sunday.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Control group:The interactive management nursing model on the wechat platform
The intervention subjects of the control group: targeted at the pregnant and postpartum women themselves. Specifically, conduct routine outpatient prenatal examinations and health education for pregnant women. Regularly receive health education and pregnancy guidance intervention provided by the wechat platform. It includes: ① Setting specific wechat ringtones, 60-second voice messages and picture reminders every day; ② Basic knowledge education every Monday ③ Dietary guidance is provided every Tuesday. ④ Exercise guidance every Wednesday ⑤ Guidance on blood glucose monitoring every Thursday; Weight guidance is provided every Friday.
Intervention group:Family-centered early care intervention
The intervention subjects of the intervention group were parturients and their primary caregivers (spouses and parents).
The specific measures are as follows:
1. Establish a family-centered healthcare team (FCC) It includes one chief physician, two attending physicians, one diabetes specialist nurse, two responsible nurses, one psychotherapist, and one nutritionist. The organization members will conduct FCC concept learning and knowledge training.
2. Interactive management nursing model on the wechat platform
* Set specific wechat ringtones, 60-second voice messages and picture reminders every day;
* Basic knowledge education every Monday; ③. Dietary guidance every Tuesday;
④. Exercise guidance every Wednesday;
⑤ Guidance on blood glucose monitoring every Thursday;
⑥. Weight guidance every Friday;
⑦. Strengthen home care guidance every Saturday and Sunday.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Primary caregiver availability: At least one primary caregiver (spouse or parent) who:
1. Demonstrates adequate verbal communication and literacy skills (assessed by standardized evaluation)
2. Voluntarily participates in the study with signed informed consent
Metabolic risk factors meeting ≥1 criterion:
1. Pre-pregnancy BMI \>24 kg/m²
2. Maternal age ≥35 years at conception
3. Documented history of polycystic ovary syndrome (PCOS)
4. Fasting blood glucose (FBG) ≥5.1 mmol/L in early pregnancy
5. Parental history of diabetes mellitus (either parent)
6. Previous gestational diabetes mellitus (GDM)
7. History of macrosomia (birth weight ≥4000g)
8. Adverse obstetric history including:
Preterm delivery (\<37 weeks) Stillbirth or fetal demise Congenital malformations Neonatal death or unexplained neonatal death
Exclusion Criteria
1. Chronic hypertension (diagnosed pre-pregnancy)
2. Renal disorders (e.g., chronic kidney disease stage ≥3)
3. Cardiovascular diseases (e.g., coronary artery disease, heart failure)
Prohibited medication use during pregnancy including:
1. Indomethacin
2. Phentolamine
3. Diuretics (e.g., furosemide, hydrochlorothiazide)
4. Phenytoin
5. Systemic corticosteroids (e.g., cortisone, prednisone)
Activity-limiting comorbidities:
a) Severe medical complications contraindicating physical activity (e.g., unstable angina, advanced respiratory failure)
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Yan Lu
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yan Lu
Clinical Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nantong First People's Hospital
Nantong, Jiangsu, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025XM105
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.